Natural Killer Cells in Chronic Lymphocytic Leukemia: Functional Impairment and Therapeutic Potential

por Yano, Max, Byrd, John C., Muthusamy, Natarajan
Publicado 2022

Tetraspanins as therapeutic targets in hematological malignancy: a concise review

por Beckwith, Kyle A., Byrd, John C., Muthusamy, Natarajan
Publicado 2015

CpG oligodeoxynucleotide CpG-685 upregulates functional interleukin-21 receptor on chronic lymphocytic leukemia B cells through an NF-κB mediated pathway

por Browning, Rebekah L., Mo, Xiaokui, Muthusamy, Natarajan, Byrd, John C.
Publicado 2015

Hearing Loss due to Infiltration of the Tympanic Membrane by Chronic Lymphocytic Leukemia

por Cohen, Jonathon B., Cavaliere, Robert, Byrd, John C., Andritsos, Leslie A.
Publicado 2012

NF-κB Functions in Tumor Initiation by Suppressing the Surveillance of Both Innate and Adaptive Immune Cells

por Wang, David J., Ratnam, Nivedita M., Byrd, John C., Guttridge, Denis C.
Publicado 2014

A Tec kinase BTK inhibitor ibrutinib promotes maturation and activation of dendritic cells

por Natarajan, Gayathri, Oghumu, Steve, Terrazas, Cesar, Varikuti, Sanjay, Byrd, John C., Satoskar, Abhay R.
Publicado 2016

Accurate quantification of DNA methylation using combined bisulfite restriction analysis coupled with the Agilent 2100 Bioanalyzer platform

por Brena, Romulo Martin, Auer, Herbert, Kornacker, Karl, Hackanson, Björn, Raval, Aparna, Byrd, John C., Plass, Christoph
Publicado 2006

MuCor: mutation aggregation and correlation

por Kroll, Karl W., Eisfeld, Ann-Katherin, Lozanski, Gerard, Bloomfield, Clara D., Byrd, John C., Blachly, James S.
Publicado 2016

The PtdIns 3-Kinase/Akt Pathway Regulates Macrophage-Mediated ADCC against B Cell Lymphoma

por Joshi, Trupti, Ganesan, Latha P., Cheney, Carolyn, Ostrowski, Michael C., Muthusamy, Natarajan, Byrd, John C., Tridandapani, Susheela
Publicado 2009

Characterization and mitigation of fragmentation enzyme-induced dual stranded artifacts

por Gregory, Thomas, Ngankeu, Apollinaire, Orwick, Shelley, Kautto, Esko A, Woyach, Jennifer A, Byrd, John C, Blachly, James S
Publicado 2020

Differential regulation of CTLA4 expression through BTK-dependent and independent mechanisms in CLL

por Yano, Max, Nunes, Jessica, Mo, Xiaokui, Rogers, Kerry A., Woyach, Jennifer A., Byrd, John C., Muthusamy, Natarajan
Publicado 2022

Controlled variable selection in Weibull mixture cure models for high‐dimensional data

por Fu, Han, Nicolet, Deedra, Mrózek, Krzysztof, Stone, Richard M., Eisfeld, Ann‐Kathrin, Byrd, John C., Archer, Kellie J.
Publicado 2022

Changes in clinical stage identify patients with CLL and different outcome within iwCLL partial response: RESONATE study

por Moreno, Carol, Delgado, Julio, Byrd, John C., Zvagelsky, William L., Suzuki, Samuel, Hsu, Emily, James, Danelle F., Montserrat, Emili
Publicado 2018

Anti-tumor NAMPT inhibitor, KPT-9274, mediates gender-dependent murine anemia and nephrotoxicity by regulating SIRT3-mediated SOD deacetylation

por Mitchell, Shaneice, Zhang, Pu, Cannon, Matthew, Beaver, Larry, Lehman, Amy, Harrington, Bonnie, Sampath, Deepa, Byrd, John C., Lapalombella, Rosa
Publicado 2021

Real‐world genomic testing and treatment patterns of newly diagnosed adult acute myeloid leukemia patients within a comprehensive health system

por Byrd, John C., Gatz, Jennifer L., Louis, Cynthia Lim, Mims, Alice S., Borate, Uma, Yocum, Ashley O., Gana, Theophilus J., Burd, Amy
Publicado 2023

Monitoring and Managing BTK Inhibitor Treatment-Related Adverse Events in Clinical Practice

por O’Brien, Susan M., Brown, Jennifer R., Byrd, John C., Furman, Richard R., Ghia, Paolo, Sharman, Jeff P., Wierda, William G.
Publicado 2021

Functional Role of mTORC2 versus Integrin-Linked Kinase in Mediating Ser473-Akt Phosphorylation in PTEN-Negative Prostate and Breast Cancer Cell Lines

por Lee, Su-Lin, Chou, Chih-Chien, Chuang, Hsiao-Ching, Hsu, En-Chi, Chiu, Po-Chen, Kulp, Samuel K., Byrd, John C., Chen, Ching-Shih
Publicado 2013

How We Manage Patients With Chronic Lymphocytic Leukemia During the SARS-CoV-2 Pandemic

por Rossi, Davide, Shadman, Mazyar, Condoluci, Adalgisa, Brown, Jennifer R., Byrd, John C., Gaidano, Gianluca, Hallek, Michael, Hillmen, Peter, Mato, Anthony, Montserrat, Emili, Ghia, Paolo
Publicado 2020

A Phase I/II Study of Etanercept and Rituximab in Patients with Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

por Woyach, Jennifer A, Lin, Thomas S, Lucas, Margaret S, Heerema, Nyla, Moran, Mollie E., Cheney, Carolyn, Lucas, David M., Wei, Lai, Caligiuri, Michael A., Byrd, John C.
Publicado 2009

Cotargeting of XPO1 Enhances the Antileukemic Activity of Midostaurin and Gilteritinib in Acute Myeloid Leukemia

por Brinton, Lindsey T., Sher, Steven, Williams, Katie, Canfield, Daniel, Orwick, Shelley, Wasmuth, Ronni, Cempre, Casey, Skinner, Jordan, Lehman, Amy, Blachly, James S., Byrd, John C., Lapalombella, Rosa
Publicado 2020